ArnoldSFreedmanMD

PubMed

• 48 citations
  The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
  Elizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, Amanda L Christie, Johannes Köster
  Cancer Cell. 2016-04-11
• 33 citations
  TGFβ-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation
  Olivier Munoz, Falko Fend, R de Beaumont, Hervé Husson, Anne Astier
  Leukemia. 2004-12-01
• 276 citations
  Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway☆
  Arnold S. Freedman, Gordon J. Freeman, K Rhynhart, Lee M. Nadler
  Cellular Immunology. 1991-10-15

Journal Articles

• Rethinking prognosis and therapy for follicular lymphoma  
  Jacobson CA, Freedman AS, J Clin Oncol, 1/1/2015
• Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia  
  Brown JR, Tesar B, Yu L, Werner L, Takebe N, Mikler E, Reynolds HM, Thompson C, Fisher DC, Neuberg D, Freedman AS, Leuk Lymphoma, 1/1/2015
• Is observation dead in follicular lymphoma? Still appropriate  
  Jacobson CA, Freedman AS, J National Comprehensive Cancer Center Network, 1/1/2015
• Follicular lymphoma: 2014 update on diagnosis and management  
  Freedman AS, Am J Hematol, 1/1/2014
• Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma  
  Jacobsen E, Pozdnyakova O, Redd R, Fisher DC, Dorfman DM, Dal Cin P, LaCasce A, Armand P, Hochberg E, Cote G, Shahsafaei A, Neuberg D, Brown JR, Freedman AS, Leuk Lymphoma, 1/1/2014
• A Phase IA/II, multi-center, open-label study of lucatumumab (HCD122) in adult patients with advanced non-Hodgkin or Hodgkin lymphoma  
  Fanale M, Assouline S, Kuruvilla J, Solal-Celigny P, Heo D, Verhoef G, Corradini P, Abramson J, Offner F, Engert A, Dyer M, Carreon D, Ewald B, Baeck J, Younes A, Free..., Br J Hematol, 1/1/2014
• Active idiotypic vaccination versus control immunotherapy for follicular lymphoma  
  Levy R, Ganjoo KN, Leonard JP, Vose JM, Flinn IW, Ambinder RF, Connors JM, Berinstein NL, Belch AR, Bartlett NL, Nichols C, Emmanouilides CE, Timmerman JM, Gregory SA,..., J Clin Oncol, 1/1/2014
• Early lymphoid lesions: conceptual, diagnostic and clinical challenges  
  Ganapathi KA, Pittaluga S, Odejide OO, Freedman AS, Jaffe ES, Haematologica, 1/1/2014
• Short Report: Detection of circulating tumor DNA in patients with aggressive B-cell non-Hodgkin lymphoma  
  Armand P, Oki Y, Neuberg DS, Faham M, Cummings C, Klinger M, Weng L, Bhattar S, LaCasce AS, Jacobsen ED, Davids MS, Jacobson C, Fisher DC, Brown JR, Fowler NH, Rodrigu..., Br J Hematol, 1/1/2013
• One size does not fill all in follicular lymphoma  
  Jacobson CA, Freedman AS, J Clin Oncol, 1/1/2013
• Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the PET era  
  Armand P, Welch S, Kim HT, LaCasce AS, Jacobsen ED, Davids M, Jacobson C, Fisher DC, Brown JR, Coughlin E, Freedman AS, Chen YB, Br J Haematol, 1/1/2013
• Giving CHOP the axe for first-line treatment of indolent lymphoma?  
  Jacobson CA, Freedman AS, Lancet, 1/1/2013
• Primary bone lymphoma involving bilateral tibia  
  Giardino AA, Shinagare AB, Shinagare SA, Dewar R, Weckstein D, Mauch P, Ramaiya NH, Freedman AS, American Journal of Hematology, 1/1/2012
• Early stage follicular lymphoma, current management and controversies  
  Jacobson CA, Freedman AS, Current Opinion Oncol, 1/1/2012
• Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined modality therapy  
  Fox AM, Dosoretz AP, Mauch PM, Chen YH, Fisher DC, LaCasce AS, Freedman AS, Silver B, Ng AK, Int J Rad Oncol Biol Phys, 1/1/2012
• Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU, and etoposide (CBV) following autologous stem cell transplant  
  Lane AA, Armand P, Feng Y, Neuberg DS, Abramson JS, Brown JR, Fisher DC, Lacasce AS, Jacobsen ED, McAfee SL, Spitzer TR, Freedman AS, Chen YB, Leuk. Lymphoma, 1/1/2012
• Germline copy number variation associated with Mendelian inheritance of CLL in two families  
  Brown JR, Hanna M, Tesar B, Pochet N, Vartanov A, Fernandes SM, Werner L, Ash M, Roden C, MacConaill L, Hainz U, Longtine J, Wang Y, Correll M, Van de Peer Y, Regev A,..., Leukemia, 1/1/2012
• Early initial therapy of advanced follicular lymphoma: the need for vigilance  
  Sweetenham JW, Freedman AS, Leuk Lymphoma, 1/1/2011
• Follicular lymphoma: 2011 update on diagnosis and management  
  Freedman AS, Am J Hematol, 1/1/2011
• A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome  
  Jacobsen ED, Kim HT, Ho VT, Cutler CS, Koreth J, Fisher DC, Armand P, Alyea EP, Freedman AS, Soiffer RJ, Antin JH, Ann Oncol, 1/1/2011
• (90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma  
  Abou-Nassar KE, Stevenson KE, Antin JH, McDermott K, Ho VT, Cutler CS, Lacasce AS, Jacobsen ED, Fisher DC, Soiffer RJ, Alyea EP, Koreth J, Freedman AS, Bone Marrow Transplant, 1/1/2011
• A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254  
  Furman RR, Grossbard ML, Johnson JL, Pecora AL, Cassileth PA, Jung SH, Peterson BA, Nadler LM, Freedman A, Bayer RL, Bartlett NL, Hurd DD, Cheson BD, For The Cancer Le..., Leuk Lymphoma, 1/1/2011
• Down-regulation of CD9 expression and its correlation to tumor progression in B cell lymphomas  
  Yoon SO, Zhang X, Freedman AS, Zahrieh D, Lossos IS, Li L, Choi YS, Am J Pathol, 1/1/2010
• Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization  
  Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR, Br J Haematol, 1/1/2010
• A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL  
  Brown JR, Abramson J, Hochberg E, Mikler E, Dalton V, Werner L, Reynolds H, Thompson C, McDonough SM, Kuang Y, Ritz J, Neuberg D, Freedman AS, Leukemia, 1/1/2010
• Join now to see all

Books/Book Chapters

• DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology 
  Chapter: Non-Hodgkin's Lymphoma. 
  Page 1552 - 1583Freedman AS, Jacobson CA, Mauch P, and Aster JCEditors: DeVita VT, Lawrence TS, Rosenberg SA.Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PAEdition 10th,2015
• Pathophysiology of Blood Disorders. 
  Chapter: Non-Hodgkin lymphomas and chronic lymphocytic leukemias. 
  Page 260 - 278Aster JC, Freedman ASEditors: Bunn HF, Aster JC.McGraw Hill, New York, NY2011
• Pathophysiology of Blood Disorders. 
  Chapter: Hodgkin lymphoma. 
  Page 279 - 286Aster JC, Freedman ASEditors: Bunn HF, Aster JC.McGraw Hill, New York, NY2011
• Cancer Medicine 
  Chapter: Non-Hodgkin's lymphomas. 
  Page 1645 - 1658Freedman ASEditors: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E.B.C. Decker, HamiltonEdition 8th,2010
• UpToDate 
  Chapter: Patient information: Follicular lymphoma in adults. 
  Freedman AS, Friedberg JWEditors: Basow DS.UpToDate, Waltham, MA2009
• UpToDate 
  Chapter: Patient information: Diffuse large B-cell lymphoma in adults. 
  Freedman AS, Friedberg JWEditors: Basow DS.UpToDate, Waltham, MA2009
• Clinical Radiation Oncology 
  Chapter: Hodgkin's disease. 
  Page 1689 - 1711Ng AK, Weiss L, Freedman AEditors: Gunderson LL, Tepper JE.Elsevier, Philadelphia, PAEdition 2nd,2006
• Clinical Bone Marrow and Blood Stem Cell Transplantation 
  Chapter: Autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. 
  Page 517 - 552Bierman PJ, Freedman ASEditors: Atkinson K, Fibbe WE, Champlin R, Ljungman P, Ritz J, Brenner MK.Cambridge University Press, Cambridge, MAEdition 3rd,2004
• Non-Hodgkin’s lymphomas. 
  Chapter: Follicular lymphoma. 
  Page 367 - 388Freedman AS, Friedberg JW, Mauch PM, Dalla-Favera R, Harris NLEditors: Mauch PM, Armitage JO, Coiffier B, Dalla-Favera R, Harris NL.Lippincott Williams and Wilkins, Baltimore, MD2004
• Harrison's Principles of Internal Medicine. 
  Chapter: Malignancies of lymphoid cells. 
  Freedman AS, Nadler LMEditors: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL.McGraw-Hill Inc., New York, NY1998
• Follicular Dendritic Cells. Current Topics in Microbial Immunol. 
  Chapter: The role of follicular dendritic cells in the regulation of B cell proliferation. 
  Page 83 - 92Freedman AS, Wang D, Manie SNEditors: Kosco-Vilbois MH.Springer-Verlag, Berlin1995
• Current Therapy in Oncology. 
  Chapter: Bone marrow transplantation in low-grade non-Hodgkin's lymphoma. 
  Page 341 - 345Freedman AS, Nadler LMEditors: Vose JM, Foley JF, Armitage JO.W.B. Saunders Co, Philadelphia, PA1994
• Harrison's Principles of Internal Medicine. 
  Chapter: The malignant lymphomas. 
  Page 1774 - 1788Freedman AS, Nadler LMEditors: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS.McGraw-Hill Inc., New York, NY1994
• Lymphocyte Adhesion Molecules. 
  Chapter: Adhesion receptors of B lymphocytes: expression and function on normal and malignant B cells. 
  Page 280 - 312Tedder TF, Engel P, Wagner N, Freedman ASEditors: Shimizu Y.RG Landes Co, Austin, TX1993
• Hematology/Oncology Clinics of North America. 
  Chapter: Developments in purging in autotransplantation. 
  Page 687 - 715Freedman AS, Nadler LMW.B. Saunders Co, Philadelphia, PA1993
• Chronic lymphocytic leukemia. 
  Chapter: Immunologic markers in B-cell chronic lymphocytic leukemia. 
  Page 1 - 32Freedman AS, Nadler LMEditors: Cheson B.Marcel Dekker, Inc, New York, NY1992
• Hematology/Oncology Clinics of North America. 
  Chapter: Immunologic markers in non-Hodgkin's lymphoma. 
  Page 871 - 889Freedman AS, Nadler LMW.B. Saunders Co., Philadelphia, PA1991
• Neoplastic Diseases of the Blood. 
  Chapter: Immunobiology of chronic leukemias. 
  Page 39 - 60Freedman AS, Griffin JD, Nadler LMEditors: Wiernick PH, Canellos GP, Kyle RA, Schiffer CA.Churchill Livingstone, New York, NY1991
• Blood Cell Biochemistry. 
  Chapter: Cell surface markers in leukemia and lymphoma. 
  Page 33 - 71Freedman ASEditors: Harris JR.Plenum Press, New York, NY1991
• The non-Hodgkin's lymphomas. 
  Chapter: Nadler LM. Bone marrow transplantation in non-Hodgkin's lymphomas. 
  Page 373 - 391Pedrazzini A, Freedman AS, Nadler LMEditors: Magrath IT.Edward Arnold, London, England1990
• Hematology/Oncology Clinics of North America. 
  Chapter: Immunobiology of chronic lymphocytic leukemia. 
  Page 405 - 430Freedman ASW.B. Saunders Co, Philadelphia, PA1990
• Hematopoietic System. Monographs on Pathology of Laboratory Animals. 
  Chapter: B-Cell function and ontogeny. 
  Page 111 - 114Freedman ASEditors: Jones TC, Ward JM, Mohr U, Hunt RD.Springer-Verlag, Berlin, Heidelberg1990
• Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias. 
  Chapter: Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement. 
  Page 265 - 283Freedman AS, Takvorian T, Nadler LM, Anderson KC, Sallan SE, Ritz JEditors: Foon K, Bennett JM.Kluwer Academic Publishers, Boston, MA1988
• Diagnostic Immunopathology. 
  Chapter: Ontogeny of Leukocytes and Leukemias. 
  Page 245 - 270Freedman AS, Griffin JD, Nadler LMEditors: Colvin RB, Bhan AK, McClusky RT.Raven Press, New York, NY1988
• Chronic Lymphocytic Leukemia. 
  Chapter: Chronic Lymphocytic Leukemia: Cell Surface Phenotype and Normal Cellular Counterparts. 
  Page 47 - 66Freedman AS, Nadler LMEditors: Polliack A, Catovsky D.Harwood Academic Publishers, Boston, MA1988
• Join now to see all

Abstracts/Posters

• Risk alleles identified in genome-wide association studies are associated with expression quantitative trait loci in chronic lymphocytic leukemia.
  Tesar B, Werner L, Hanna M, Improgo MR, Pochet N, Fernandes SM, Macconaill L, Regev A, Freedman, AS, Neuberg DS, Freedman ML, Brown JR, Blood; ASH, 1/1/2012
• Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the PET era.
  Welch S, Armand P, Kim HT, LaCasce AS, Jacobsen E, Davids MS, Jacobson CA, Fisher DC, Brown JR, Freedman AS, Coughlin E, Chen YA, Blood; ASH, 1/1/2012
• Anti-CD40 monoclonal antibody lucatumumab exhibits anti-tumor activity in follicular lymphoma and other lymphoma subtypes: phase I/II preliminary findings.
  Freedman A, Kuruvilla J, Assouline S, Engert A, Heo D, Solal-Celigny P, Corradini P, Verhoef G, Younes A, Bendiske J, Ewald B, Dey J, Baeck J, Bilic S, Rediske J, and ..., Ann Oncol; International Conference on Malignant Lymphoma, 1/1/2011
• Obataclax in combination with fludarabine and rituximab FR) is well-tolerated is shows promising clinical activity in relapsed CLL/SLL.
  Brown JR, Tesar B, Werner L, Mikler E, Reynolds H, Thompson C, Fisher DC, Takebe N, Neuberg D, Freedman AS, Blood; ASH, 1/1/2011
• Novel germline genetic variants associated with familial chronic lymphocytic leukemia (CLL).
  Brown, JR, Lawrence MS, Hanna M, Tesar B, Stojanov P, Vartanov AR, Fernandes SM, Sougnez C, MacConaill L, Pochet N, Regev A, Werner L, Gabriel S, Lander ES, Neuberg D,..., Blood; ASH, 1/1/2011
• Multi-trial safety evaluation of the fully antagonistic human anti-CD40 monoclonal antibody lucatumumab (HCD122) in patients with relapsed or refractory B-cell maligna...
  Fanale, F, Bensinger WI, Byrd JC, Ewald B, Carreon D, Baeck J, Freedman AS, Blood; ASH, 1/1/2011
• A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab In Relapsed CLL/SLL.
  Brown JR, Messmer B, Werner L, Mikler E, Fisher DC, LaCasce A, Armand P, Jacobsen E, Dalton V, Tesar B, Fernandes SM, McDonough S, Ritz J, Rassenti LZ, Kipps TJ, Neube..., Blood; ASH, 1/1/2010
• Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated in a Phase Ia/II Clinical Trial (NCT00670592)
  Freedman AS, Kuruvilla J, Assouline SE, Engert A, Heo D, Solal-Celigny P,Corradini P,Verhoef G,Fanale MA, Bendiske J, Ewald B, Dey J, Baeck J, Younes A, MD, Blood; ASH, 1/1/2010
• Join now to see all

Lectures

• PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Pha... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical Aspects of Lymphoma/Myeloma 
  Harvard Medical School - 1/1/2015
• Non-Hodgkin’s Lymphoma 
  Harvard Medical School - 1/1/2015
• Med-Path Conference 
  Brigham and Women’s Hospital - 1/1/2015
• High grade lymphomas. 
  1/1/2015
• Stem cell transplantation for non-Hodgkin lymphoma. 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2014
• Update on therapy for non-Hodgkin’s lymphoma. 
  Brigham and Women’s Hospital, Boston, MA - 1/1/2014
• Update on management of lymphomas and chronic lymphocytic leukemia. 
  Boston, MA - 1/1/2014
• Maintenance therapy for lymphoma. 
  Brooklyn, NY - 1/29/2013
• Update on follicular lymphomas and the role of stem cell transplantation. 
  Tufts Medical Center, Boston, MA - 1/1/2013
• Autologous and allogeneic stem cell transplantation in follicular non-Hodgkin lymphoma. 
  Herzlia, Israel - 1/1/2012
• ASH 2011 Meeting Highlights, Lymphoma 
  Boston, MA - 1/1/2012
• Update on management of lymphoma and chronic lymphocytic leukemia. 
  Boston, MA - 1/1/2012
• Annual Meeting Plenary Session Introduction: An Intergroup Randomized Trial of Rituximab Versus a Watch and Wait Strategy in Patients with Stage II, III, IV, Asymptoma... 
  Orlando, FL - 1/1/2010
• Clinical Activity of Lucatumumab (HCD122) in Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated in a Phase Ia/II Clinical Trial (NCT006705... 
  Orlando, FL - 1/1/2010
• The role of stem cell transplantation for follicular lymphoma. 
  Jerusalem, Israel - 1/1/2010
• Update on follicular lymphomas. 
  Kaplan Medical Center, Rehovat, Israel - 1/1/2009
• Lymphoma Update 
  New York, NY; Chicago, IL; San Francisco, CA; Miami, FL; Pasedena, CA; Los Angeles, CA - 1/1/2009
• Follicular Lymphomas 
  University of Kansas Medical Center, Kansas City, KS - 1/1/2008
• Current treatment of follicular lymphoma. 
  St. Elizabeth’s Hospital, Boston, MA - 1/1/2008
• Update on follicular lymphoma. 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2008
• Tumor Board 
  Emerson Hospital - 1/1/2008
• Update on treatment of diffuse large B cell lymphoma. 
  Baystate Medical Center, Springfield MA - 1/1/2007
• Update on the Management of patients with Hematologic Malignancies, Immunologic Management of Low Grade Lymphoma 
  Massachusetts General Hospital, Boston, MA - 1/1/2007
• Join now to see all

Other

• Castleman's disease. 
  Aster JC, Brown JR, Freedman AS, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Overview of the pathobiology of the non-Hodgkin lymphomas. 
  Brown JR, Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Pathobiology of Burkitt lymphomas: Overview. 
  Brown JR, Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma. 
  Brown JR, Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Pathobiology of mantle cell lymphoma. 
  Brown JR, Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Pathobiology of the indolent non-Hodgkin lymphomas. 
  Brown JR, Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical presentation and diagnosis of primary gastrointestinal lymphomas. 
  Freedman AS, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Management of gastrointestinal lymphomas. 
  Freedman AS, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of adult T cell leukemia-lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of anaplastic large cell lymphoma T/null cell type. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of angioimmunoblastic T-cell lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of B cell prolymphocytic leukemia. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of extranodal (MALT) and nodal marginal zone lymphomas. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of extranodalNK/ T cell lymphoma, nasal type. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of follicular lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of hepatosplenic T-cell lymphomas. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of lymphoplasmacytic lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of peripheral T-cell lymphoma, not otherwise specified. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of precursor B-cell acute lymphoblastic leukemia/lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of precursor T-cell acute lymphoblastic leukemia/lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of primary mediastinal large B-cell lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of small lymphocytic, lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Clinical manifestations, pathologic features, and diagnosis of splenic marginal zone lymphoma. 
  Freedman AS, Aster JC, UpToDate; Basow DS (Ed)
  Waltham, MA - 1/1/2014
• Join now to see all